GlaxoSmithKline PLC's leading sales in the US OTC smoking cessation category could grow with its proposal for the first mouth spray product to be available Rx or nonprescription in the country.
The Food and Drug Administration has scheduled a Nonprescription Drugs Advisory Committee meeting for 18 September to consider GlaxoSmithKline Consumer...